Distribution of ESBL-producing enterobacteria associated to community-acquired monomicrobial urinary tract infections and antimicrobial susceptibility trends over a 9-year period
Urinary tract infections (UTIs) are among the most common infectious diseases affecting men and especially women, with increased frequency related to gender and age.1 In general, treatment is empiric and regional, with several expanded-spectrum antimicrobials supported most of the time, by microbiological and epidemiological data provided by antibiotic resistance surveillance systems.2 When considering the worldwide spread of bacterial resistance determinants, prospective regional and international data on aetiology and drug susceptibility patterns of bacteria
related to UTI are important.3,4 Additionally, the characteristics of the disease, whether it is a nosocomial or community-related UTI, are known to play an important role in empirical antimicrobial therapy, especially when considering urinary tract pathogens.5
*Não disponível em português.
Para acessar o artigo na integra, clique aqui!